Quantity size:
0.2ml
Concentration:
1mg/ml 法尼基二磷酸法尼基转移酶1/鲨烯合成酶抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Several proteins mediate the biosynthesis of cholesterol. The first specific step in the cholesterol biosynthetic pathway is the conversion of transfarnesyl-diphosphate to Squalene, which is catalyzed by the endoplasmic reticulum membrane-associated enzyme Squalene synthetase, 法尼基二磷酸法尼基转移酶1/鲨烯合成酶抗体also designated Squalene synthase and Farnesyl-diphosphate farnesyltransferase. Squalene synthetase is located at a branch point in the mevalonate pathway and is also involved in isoprenoid biosynthesis. Squalene epoxidase, also designated Squalene monooxygenase, is a multi-pass microsomal membrane-associated enzyme that catalyzes the first oxygenation step in sterol biosynthesis and most likely functions as one of 法尼基二磷酸法尼基转移酶1/鲨烯合成酶抗体the rate-limiting enzymes in this pathway. Squalene epoxidase may form a complex with Squalene synthetase.
法尼基二磷酸法尼基转移酶1/鲨烯合成酶抗体Also known as:
DGPT; ERG9; Farnesyl diphosphate farnesyltransferase 1; Farnesyl diphosphate farnesyltransferase; Farnesyl-diphosphate farnesyltransferase; FDFT_HUMAN; FDFT1; FPP:FPP farnesyltransferase; Presqualene di diphosphate synthase; SQS; Squalene synthase; Squalene synthetase; SS.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human FDFT1.
●
Predicted Molecular Weight: 48kDa.
法尼基二磷酸法尼基转移酶1/鲨烯合成酶抗体Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl218Cp01转化生长因子β2(TGFβ2)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
kl218Ga01转化生长因子β2(TGFβ2)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
kl218Po01转化生长因子β2(TGFβ2)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
kl218Rb51转化生长因子β2(TGFβ2)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
kl218Si01转化生长因子β2(TGFβ2)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
kl220Bo01肾上腺髓质素(ADM)多克隆抗体Polyclonal Antibody to Adrenomedullin (ADM)
kl220Ca01肾上腺髓质素(ADM)多克隆抗体Polyclonal Antibody to Adrenomedullin (ADM)
kl220Eq01肾上腺髓质素(ADM)多克隆抗体Polyclonal Antibody to Adrenomedullin (ADM)
kl220Hu01肾上腺髓质素(ADM)多克隆抗体Polyclonal Antibody to Adrenomedullin (ADM)
kl220Mu01肾上腺髓质素(ADM)多克隆抗体Polyclonal Antibody to Adrenomedullin (ADM)
kl220Po01肾上腺髓质素(ADM)多克隆抗体Polyclonal Antibody to Adrenomedullin (ADM)
kl220Ra01肾上腺髓质素(ADM)多克隆抗体Polyclonal Antibody to Adrenomedullin (ADM)
kl221Mu01转录因子20(TCF20)多克隆抗体Polyclonal Antibody to Transcription factor 20 (TCF20)
kl222Bo01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)
kl222Ca01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)
kl222Eq01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)
kl222Ga01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)
kl222Hu01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)
kl222Mu01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)
kl222Po01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)
kl222Ra01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)
kl222Si01干扰素β(IFNβ)多克隆抗体Polyclonal Antibody to Interferon Beta (IFNb)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话